Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases, and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at www.alcon.com
Santen Pharmaceutical is one of the world’s leading specialist ophthalmic pharmaceutical companies, founded in Japan over a century ago and now serving patients all over the world. We’re the ophthalmology market leader in Japan. We’ve been active in the European market since 1994 and are enjoying strong growth in EMEA (Europe, Middle East, Africa) and worldwide. We’re passionate about improving eye health and vision for patients and making beneficial treatments accessible to patients and healthcare systems. With our sole focus being ophthalmology, we can assess, respond and act quickly in this specialist field where we have deep knowledge and experience.
With our focus on the sense of eyesight, there’s a huge and unique opportunity to improve quality of life for patients while sustaining a strong and effective commercial organisation. As populations age, patient numbers are growing, driven by conditions like glaucoma and retinal disorders. The prescription ophthalmic pharmaceutical market is growing rapidly as new treatment and diagnosis methods emerge from evolving technology. There are significant unmet patient needs in ophthalmology.
Prescription ophthalmic pharmaceuticals are our core business, accounting for over 80% of our global net sales. We also provide over the counter eye treatments and medical devices as well as nutritional products for eye health. In EMEA, we are a leader in glaucoma and dry eye treatment – areas in which our portfolio serves every stage and type of disease. We are also growing our range in eye infections, allergies, and devices for vision correction and glaucoma surgery.
Bausch + Lomb, is a multinational pharmaceutical company renowned for its focus on eye health products, including contact lenses, lens care products, medicines, and implants for eye diseases. Our mission is simple, yet powerful: helping you see better to live better all over the world—that’s why we started and what we still strive for today. Through unwavering focus rooted in innovation, quality and craftsmanship, we continue to pursue our lifelong vision of protecting and enhancing the gift of sight through every phase of life. For nearly two centuries, we’ve been inspired and honored by our mission of helping people see better to live better.
EssilorLuxottica is a global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses. With over 200,000 employees across 150 countries, 650 operations facilities and 18,000 stores, in 2023 the Company generated consolidated revenue of Euro 25.4 billion. Its mission is to help people around the world to see more and be more by addressing their evolving vision needs and personal style aspirations. EssilorLuxottica is home to the most advanced lens technologies including Varilux, Stellest and Transitions, the most iconic eyewear brands including Ray-Ban and Oakley, the most desired luxury licensed brands and world-class retailers including LensCrafters and Sunglass Hut. The Company’s OneSight EssilorLuxottica Foundation has given access to sustainable vision care to more than 760 million people in underserved communities.
World-Class Quality, Efficacy & Excellence Jamjoom Pharma merges global best practices with local expertise to maximize value creation for key stakeholders, while reinforcing our position as a leading pharmaceutical manufacturing organization in the Middle East and Africa region.
Our strategy is tailored to accelerate and prioritize growth by exploring and expanding into key markets, while creating a positive and lasting impact in the communities we operate in. We strive to optimize operational efficiencies in manufacturing to drive cost reduction and minimize waste, as well as contributing to national and regional self-sufficiency. This enables us to reinforce our position as a key strategic supplier to the Kingdom’s public healthcare system, in line with Vision 2030 and the National Transformation Program.
Sight is a key component in the way many of us experience the world, learn and remember, and what many fear losing the most. We at Johnson & Johnson build on a 135-year legacy to tackle the most pervasive and complex eye health challenges for people around the world and care for 40 million people’s vision each year. Our vision is to be the leader in eye health for a patient’s lifetime journey and our mission is to help very human see their world clearly. We are continually transforming how vision is corrected and eyes cared for and most recently, we are doing that with our latest innovation in Intra-Ocular Lenses, TECNIS PureSee™ and our latest innovation in refractive vision correction, ELITA™.
ESTABLISHED IN 1994, MEDICALS INTERNATIONAL IS A DISTRIBUTOR OF SPECIALIZED MEDICAL AND OPTICAL SUPPLIES TO THE MENA REGION, CYPRUS, GREECE, AZERBAIJAN & TÜRKİYE WITH 19 OFFICES OPERATING REGIONALLY.
Medicals International is headquartered in Lebanon and caters to a wide range of clients including the region’s top tier medical institutions and establishments.
Medicals International has distribution channels dealing in product lines as well as medical equipment in the fields of vision care, ophthalmology, dentistry, and critical care.
Medicals International runs smaller subsidiaries in each of the territories it covers, which creates four major advantages:
With a vast product portfolio of specialized international brands and over 30 years of solid experience in the industry, Medicals International has established itself as one of the leading medical distribution firms in the region.
Established in 1984, AMICO Group is a leading distributor of medical devices across the MENA region, with a footprint in 12 countries. AMICO Group excels in delivering cutting-edge medical technologies in areas such as ophthalmology, orthopedics, neurosurgery, dermatology, general surgery and wound, ENT, Vision Care, spinal surgery and IVD.
AMICO Group distinguishes itself by not only offering the latest in medical technology but also by providing comprehensive medical education and training to specialists. This dual focus ensures that healthcare professionals are well-equipped with the newest innovations to deliver superior patient care. AMICO Group’s dedication to technology, education, and innovation has solidified its status as a trusted partner for healthcare providers throughout the MENA region.
ZEISS is an internationally leading technology enterprise operating in the optical and optoelectronics industries. As a company wholly owned by a foundation, ZEISS is rooted in and committed to responsibility in all its activities. As a pioneer of scientific optics, we continue to challenge the limits of human imagination. With our passion for excellence, we create value for our customers and inspire the world to see in new ways.
The company was founded in 1846 by Carl Zeiss, who anchored precision, a commitment to innovation and the creation of real value for customers and society. In 1889, Ernst Abbe established the Carl Zeiss Foundation in memory of his partner as the sole owner of ZEISS, until today the foundation is exclusively committed to promoting science and progress. As a pioneer of corporate responsibility ZEISS is following a clear path: enabling customers to achieve their goals with value-added solutions developed and manufactured in a responsible manner.
VSY Biotechnology Gmbh is a progressive and innovative company that focuses on consumer satisfaction by creating superior state-of-the-art ophthalmology and orthopedics products designed and manufactured to greatly enhance and improve vision and comfort for a wide range of patients around the globe.
Product portfolio includes intraocular lenses to treat cataract and refractive errors like presbyopia, astigmatism and ocular problems, as well as injector and cartridge systems , viscoelastics for ophthalmology and orthopedics and hyaluronic acid (HA) viscosupplement products for orthopedics.
Starting from foundation to today, quality and safety standards are the source of our success. We are serving over 80 countries around the globe from our headquarters with a professional marketing and distribution approach.
Italian multinational company, with R&D, manufacturing, marketing and sales capabilities, and an extensive product portfolio mainly based on hyaluronic acid (HA) in joint care, skin care, eye care, aesthetic care, specialty care and regenerative care. Over 60 years of R&D have placed Fidia at the forefront in the production of natural and functionalized HA, with different ranges of molecular weight (~1,200 patents). Manufacturing operations – located in Italy – are inspected and approved by major international health authorities, including the US and Korean FDA, the Brazilian ANVISA and G-MED Notified Body, and comply with the strictest international regulations and safety standards. Fidia extends its global reach through local partners in +120 countries worldwide, as well as wholly owned subsidiaries in USA, Germany, Austria, Spain, France, Russia, Czech Republic, Slovakia, Romania, Poland, Egypt and Middle East.
Fidia has more than 1,600 global employees and boasts a turnover exceeding €463 million (2023), nearly 50 percent of which is generated abroad.
Haag-Streit Group is an international medical device company in the field of eye care. The Group develops, manufactures, and globally distributes cutting-edge solutions and medical devices with a portfolio that includes slit lamps, biometers, perimeters, surgical microscopes, furniture for the refractive workplace, and VR-based solutions and simulators for medical education.
Founded in 1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world’s largest biotechnology company and the global leader in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics for improving and saving the lives of people around the world. We are a pioneer in
personalised healthcare and want to further transform how healthcare is delivered to have an even greater impact. To provide the best care for each person we partner with many stakeholders and combine our strengths in Diagnostics and Pharma with data insights from the clinical practice. In recognising our endeavor to pursue a long-term perspective in all we do, Roche has been named
one of the most sustainable companies in the pharmaceuticals industry by the Dow Jones Sustainability Indices for the thirteenth consecutive year. This distinction also reflects our efforts to improve access to healthcare together with local partners in every country we work. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder
in Chugai Pharmaceutical, Japan. For more information, please visit www.roche.com.
Thea is a family owned business with European roots. It is a pharmaceutical company specializing in eye care products.
With a legacy of innovation dating back 150 years, and the dedication of 5 generations of the Chibret family, this highly respected ophthalmic endeavor is carried on today by Jean-Frédéric Chibret. We serve the complex needs of eye care professionals and extend our reach and bring our history of expertise and passion to 75 countries.
Orchidia Pharmaceutical Industries, with 30 years of excellence in providing high-quality intelligent ophthalmic solutions, is proud to be a unique model of a specialized manufacturer for ophthalmic products through its owned state-of-the-art manufacturing facility in a 6000 m² area equipped with the latest high-tech. sterile 8 production lines producing different ophthalmic dosage forms of 65 products, in addition to a promising pipeline filled with the recent approved molecules to be introduced to our patients.
Orchidia is honored to be ranked No.1 in the Egyptian ophthalmology market, which reflects ophthalmologists trust in Orchidia’s products; this is not only in Egypt but also in the West African region based on the recent IMS data. Orchidia is pursuing a rapid global expansion strategy. We currently operate in 42 countries throughout Africa, the Gulf, the CIS, and Russia. In 2025, we plan to expand into Europe.
As per our responsibility towards the ophthalmology society, Orchidia is focused on developing and contributing to continuous medical education programs to deliver the latest scientific updates and technologies to all segments of ophthalmology HCPs, along with numerous campaigns for awareness, early diagnosis, and management of eye diseases that serve our patients.
SOLMED is a private company that offers consultancy, solution implementation and supply of the latest products for the healthcare sector in the Middle East and Africa. Since its founding, in 2008, SOLMED has redefined healthcare standards. We remained true to our original belief and broadened our vision to establish SOLMED as the benchmark provider of high quality advisory services.
For over 30 years, UFSK-International OSYS has been a leading developer of highly specialized mobile surgical tables and operating room chairs for ophthalmology. Our owner-managed company, led by Jürgen Scherrieble, is dedicated to combining technical innovation with international expertise. We are committed to delivering high-quality medical devices while fostering a work environment built on trust and respect. Our focus remains on medical progress and customer-driven solutions that enhance surgical efficiency worldwide.
At UFSK-International OSYS, we believe in developing products by practitioners, for practitioners. Our mission is to provide ergonomic, durable, and service-friendly surgical solutions that meet the high patient throughput demands of ophthalmology. By working closely with renowned international ophthalmic surgeons, we ensure that our products are tailored to the real-world needs of medical professionals.
Our vision is to set new standards in ophthalmic surgical equipment by integrating cutting-edge technology with practical application, enabling efficient and safe surgical procedures worldwide.
Excellent hi-care was established in 1995 manufacturing and marketing of Intraocular lenses and ophthalmic surgical products. (Implantable Contact Lens(ICL), Toric Hydrophobic and Hydrophilic Lens, Trifocal Hydrophobic and Hydrophilic Lens, Multifocal Hydrophobic and Hydrophilic Lens, Opthalmic Solution Lens,Hydrophobic Foldable Intraocular lenses, 360 degree Hydrophilic Acrylic Foldable IOLs, PMMA Single Piece IOls and Ophthalmic knives/blades). The products are manufacturing as per Good manufacturing practices with state of the art technology. Our products are well recognized and using in leading eye care institutions and ophthalmologists in more than 35 countries worldwide.
Our company complies ISO 13485:2016 quality management systems and most of our products are CE certified to confirming the products are manufactured as per international quality standards.
Optitech Eyecare, a leading manufacturer of high-quality ophthalmic products & equipment. With over 30 years of experience in the industry, we have established ourselves as a trusted name in the market.
At Optitech Eyecare, we specialize in designing, manufacturing and distributing a wide range of ophthalmic products including ophthalmic strips, solutions, devices, Surgical Instruments and equipment. Our products are made with the highest quality materials and are rigorously tested to ensure they meet the highest standards of quality and safety. We are an ISO 13485 Certified Company and have products.
Adjusting to change and leading the way: Our purpose is to make an impact that matters. This together with our team’s shared vision, gives us the foundation for what we stand for and who we are, and how we work at Euyuncare.
We have evolved as company which takes our profession ethically following all quality standards within our industry, making sure our products can withstand the most robust tests, exceeding in quality.
Through our teams’ efforts and headstrong factors, we today stand in the UAE as company which has not only faced severe competition, but has come out on top, and leading the market in Specialty and Phakic Contact lenses.
About Us:
Founded in the United Arab of Emirates in 2017 by a private and professional proprietor. Euyuncare is a trading company of Ophthalmic equipment, Implantable Phakic Contact Lens and EDOF IOLs, Low Vision Aid Devices and Technology, Surgical Instruments, Ophthalmic Consumables, Human Tissue and Specialty Contact Lenses.
We are dedicated to build and establish relationships with manufacturers of leading technology in the optical industry.
Our commitment to deliver high-quality ophthalmology products and solutions coupled with exceptional service has allowed us to be recognized in today’s market. We have expanded to become a provider of high-quality and cost-effective ophthalmic products & correction solutions within our portfolio of hospitals, clinics and medical centers in the UAE.
Sign up now to our newsletter
